Why Healthline chooses Cornbread Hemp for pain relief
Christy Snyder has tested over 50 CBD brands and 100 CBD products for Healthline. She praised Cornbread Hemp Distilled Oil for helping her manage anxiety and insomnia, noting benefits for physical tension and back pain.
'About an hour after taking this oil, I felt both physically and emotionally less anxious and tense, which helped me to fall asleep. For me, when I can reduce my physical symptoms of anxiety (tension in my shoulders and neck, heart racing), it helps to slow down and decrease any intrusive or racing thoughts.'
'I've also been dealing with some back pain, and I noticed that this reduced some of the pain.'
Christy was a fan of the flavor. 'I found this oil to have a buttery taste — maybe from the MCT oil, but it was stronger in flavor than other oils I've tried. I really liked that it tasted buttery — I am a lover of movie theater butter popcorn. I didn't notice much of a hemp-y taste, which was pleasant.'
She also considers Cornbread Hemp to be great value for money. 'This oil is SUPER affordable for the typical price/contents of a full-spectrum CBD oil. Some of them go for $100+, and this one is under $100 by quite a bit. It's great value, and I like that it's USDA organic.'
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Medscape
24 minutes ago
- Medscape
Dealing With Death: Unavoidable Med Student Rite of Passage
When Kristina Newport, MD, was a first-year medical resident doing a night shift at a small veterans' hospital, one of her patients, who was very sick with multiple chronic diseases, made the decision to forego further treatments. She found herself in a 'profound discussion' with her senior resident and attending physician about their patient. Newport recognized a major shift from what she was used to. 'It felt like such a contradiction of what my job was…just thinking about the possibility that we would let him die naturally,' she said. As the night wore on, she checked on the patient often to make sure he was comfortable and peaceful. Nurses reassured her that the team was doing the right thing. Ultimately, this patient died peacefully with his daughter sitting next to him. For Newport, the experience was 'remarkable' and transformative and led her to go into palliative care medicine. It was also so different from many of the patient deaths that followed, where the teams she was part of tried many interventions to no avail. 'Our job is to alleviate suffering,' Newport told Medscape Medical News . 'And sometimes that means allowing people to die naturally. And so, my first experience really cemented that and helped me to understand how valuable it is to play a therapeutic role in that situation and allow that process to happen.' Doctors and medical trainees experience a patient's death differently, said Newport, who is now chief of Palliative Care Medicine for Penn State Health in central Pennsylvania and is chief medical officer for the American Academy of Hospice and Palliative Medicine. If someone has had a friend or loved one die, 'that will change how they experience their first time that a patient dies,' she said. On top of that, the intensity of dying and death manifests in different ways. 'Sometimes death is very quiet,' she said. It can happen while a trainee is making small talk with the family. 'And other times it's really dramatic, where somebody has had a trauma or a cardiac arrest and they are pronounced dead after an attempted resuscitation.' The response and experience of the medical trainee might be different depending on those circumstances, she said. '…It is a pretty profound experience, and something that if it's the first time the trainee has ever experienced someone dying, it's important to allow them to have those feelings and just recognize that it really is something unique that they are a witness to.' 'Medicine Isn't Only About Interventions' When a patient dies, it can be disorienting for medical trainees, Raya Kheirbek, MD, MPH, said in an email. A patient death can feel like a failure even when it isn't, said Kheirbek, chief of the Division of Gerontology, Geriatrics, and Palliative Medicine at the University of Maryland School of Medicine in Baltimore. A trainee can feel fear, helplessness, and even shame. Being present matters, she said. Raya Kheirbek, MD, MPH 'Medicine isn't only about interventions or cures; sometimes it's just about bearing witness. Sitting beside someone in their final moments, listening to their fears, holding a hand when there's nothing left to do — these acts carry weight…,' she said. That is the practice of medicine, too. When a patient dies, 'don't rush through it. Don't turn away from the discomfort…,' Kheirbek added. 'You don't need to have the perfect words.' Families remember whether you were present, honest, and kind, she said. 'Real Doctoring' 'Every physician has a first patient who dies, and it's often sad and wrenching. And it's an initiation into real doctoring,' said Ira Byock, MD, professor emeritus at Dartmouth's Geisel School of Medicine in Hanover, New Hampshire. It can be draining to take care of dying patients, he said, but 'there are more than a few times when we can also be filled up by the privilege and profound meaning of accompanying somebody during these intimate times of their lives.' Ira Byock, MD Byock directed the palliative care program at Dartmouth's Geisel School of Medicine for 10 years and is the author of a number of books including Dying Well and The Four Things that Matter Most . Most of the time, doctors provide care by diagnosing and treating physical ailments, Byock said. 'But sometimes doctoring requires being present, showing up and leaning forward, and attending to their [the patient's] physical, emotional, and social well-being.' Process With Others After a patient dies, pay close attention to how your mentors approach these moments, Kheirbek said. 'Ask them how they process it, what they've learned over time. There's wisdom in those quiet conversations.' It may be particularly challenging for trainees who were peripherally involved in the patient's care, Newport said. 'You don't really understand why the person died, but you're expected to just move on because you weren't closely involved. And so, I think those situations are some of the harder ones.' She encourages trainees to ask their senior residents and attendings questions like, Can you help me understand what happened? Or why did we do it the way we did? If they're not in an environment that is conducive to raising these questions, they can seek out someone else to help them work through things, she said. There may be times when there were mistakes or questionable actions that occurred before a patient died, and this 'can really lead to some complicated feelings about what happened,' Newport said. In those situations, it is important to talk through that because it can be 'a very burdensome feeling' if the trainee feels like something they did contributed to the patient's death, she said. Kayla Fresco, MD, who just completed her third year of residency in internal medicine at Penn State Health Milton S. Hershey Medical Center, Hershey, Pennsylvania, has questioned herself after a patient died. Kayla Fresco, MD 'I think that's been one of the things that's been hard…to sort of overcome because you have all these thoughts. There's on the one hand, 'What did I do objectively? Did I do everything right in the code?' And you're sort of second-guessing or 'Is there something I could have done?'' Fresco has found it most helpful to debrief with others on her team after a patient death. 'And it's something that I've continued to appreciate in other code situations throughout training,' Fresco said. Byock advises young trainees to normalize the expectation that they will care for patients who die. 'Don't let it devastate you. Let it impact you,' he said. There are also rituals that healthcare providers can conduct to create positive meaning. Kheirbek makes a point to pause after each death. 'I stay in the room, even briefly. I say their name. I acknowledge their life,' she said. If the family is there, 'I try to meet them with honesty and presence.' Newport keeps the names of all the people who died under her care, and she reaches out to their family members. Just the simple act of 'validating and making space for the loved ones is therapeutic,' she said. You can say to a patient's family member something as simple as: 'This is really sad.' Fresco tries to slow down the process after a patient dies. She waits a little longer than is typical to perform a death exam. And then while performing it, she always uses the patient's name 'to really respect that person and…show respect for their family and recognize the value of their life, no matter what the medical outcome is,' she said. 'When you're faced with it [death] that close, it makes you question sort of your own mortality,' Fresco said. Fresco has learned that grief can take many forms. Some of the most difficult situations are when the family is not prepared for the patient's death. She once took part in an hour and a half long code for a 35-year-old patient. When the team stopped compressions, a family member ran into the room and yelled at them to keep going. 'Part of the process as a provider grieving is me knowing that the family is grieving and that I shouldn't take those things personally when the family comes and yells at me,' Fresco said. Over time, medical trainees may become more comfortable in dealing with death, 'but…it always still has an effect,' Newport said. 'I think the way that it's changed for me is that rather than it being a scary experience, I view it more as a, a very, almost sacred or very precious experience to be able to…be with people in their final moments,' Fresco said. Yet it's also sometimes overwhelming and exhausting, she added. Don't Neglect Yourself It is essential for medical students and residents to take care of themselves when a patient is dying and after death has occurred, experts said. 'We ask a lot of our trainees. They're human beings, and it's important that they maintain their humanity in this space,' Newport said. Medical trainees should not feel like they have to hide their emotions, particularly the first time they experience a patient's death, Newport said. 'It's totally normal to have any range of emotions.' She recommends trainees think about a twofold response — how you can be there for the patient and family members and also make space for your own emotions. 'If we don't make space for our own sorrow, we risk becoming detached, even numb,' Kheirbek said.
Medscape
33 minutes ago
- Medscape
ACG Updates Guidance on Crohn's Disease Management
The American College of Gastroenterology (ACG) has issued updated guidance on the management of Crohn's disease (CD) that reflects the surge in development of therapeutic options available since 2018, when the last guideline was published. These newer treatment options include interleukin-23 (IL-23) blockers risankizumab, mirikizumab, and guselkumab; the anti-IL-12/23 agent ustekinumab; the JAK inhibitor upadacitinib; and the anti-integrin vedolizumab. The intent of the guideline is to suggest 'preferable approaches' to CD management established through 'interpretation and collation of scientifically valid research, derived from extensive review of published literature,' said the writing group, led by Gary Lichtenstein, MD, director, Inflammatory Bowel Disease Center, Hospital of the University of Pennsylvania, Philadelphia. When exercising clinical judgment, the authors advise healthcare providers to 'incorporate this guideline along with patient's needs, desires, and their values to care for patients fully and appropriately with CD.' The guideline is intended to be 'flexible, not necessarily indicating the only acceptable approach,' and shared decision-making with the patient is advised, they stressed. The 40-page guideline was published online earlier this month in American Journal of Gastroenterology, along with a one-page visual highlights summary . From Diagnosis to Surgery The incidence of CD has steadily increased over the past several decades, and both the diagnosis and treatment of patients with CD has evolved since 2018. Table 1 of the guideline outlines all 35 recommendations for management of CD, which span diagnosis, endoscopy, medical management (broken down by mild-to-moderately severe disease with a lower or higher risk for disease progression), fistulizing CD, when to refer to surgery, and postoperative care (according to low and high risk for postoperative recurrence). Table 2 of the guideline offers 59 'key concepts' covering clinical features, natural history, intestinal malignancy, diagnosis, disease modifiers, and medical and surgery management. In making a diagnosis, it's important to consider clinical presentation as well as endoscopic, radiologic, histologic, and pathologic findings, the authors said. They advise using fecal calprotectin (cutoff > 50-100 ug/g) to differentiate inflammatory from noninflammatory disease of the colon. Routine endoscopic surveillance for colorectal cancer in patients with Crohn's colitis is also recommended. Medical Treatment 'Medical treatment of CD is usually categorized into induction and maintenance therapy,' the authors wrote. Treatment regimens are usually chosen with 'a goal to achieve clinical and biomarker response within 12 weeks of treatment initiation followed by durable steroid-free control of disease activity including both clinical and endoscopic remission.' However, objective outcomes like endoscopic improvements have only recently been added to clinical trials, they noted. The authors stressed that early initiation of advanced therapy is 'key' for optimal outcomes and that failure of conventional therapy before initiation of advanced therapy is not required. For mild to moderately severe disease (with a lower risk for progression), oral mesalamine is not recommended for induction or maintenance; ileal release budesonide is recommended for induction but not maintenance; and sulfasalazine should be considered only for those with symptomatic mild colonic CD. For moderate to severe CD (with a higher risk for progression) there are 17 recommendations, including: Oral corticosteroids are recommended for short-term induction of remission but not maintenance. Azathioprine and 6-mercaptopurine are not recommended for induction of remission but are recommended for maintenance of remission, with thiopurine methyltransferase testing done before initiation. However, given the adverse effect profile of thiopurine monotherapy, newer safer agents for maintenance should be considered. Methotrexate for maintenance of steroid-free remission is suggested. Anti-TNF agents (IV infliximab; SC adalimumab or certolizumab pegol) are recommended for induction and maintenance; SC infliximab for maintenance only; TB and hepatitis B status should be checked before treatment. Vedolizumab, ustekinumab, upadacitinib, guselkumab, mirikizumab, and risankizumab are all options for induction and maintenance. For fistulizing CD, infliximab, adalimumab, antibiotics, upadacitinib, vedolizumab or ustekinumab are recommended options for induction of remission. Referral to Surgery In terms of when to refer to surgery, patients with an intra-abdominal abscess > 2 cm should be treated with drainage and antibiotics. Patients with symptomatic fibrostenotic strictures or abdominal abscesses should be considered for surgery, the authors advised. In patients with surgically induced remission, colonoscopy 6-12 months after surgery is recommended to assess for early recurrent CD. Patients with a low post-op risk of recurrence can be observed. Patients with a high risk of post-op recurrence should consider starting advanced therapy shortly after resection with an anti-TNF agent or vedolizumab. High-risk patients include active smokers, those with penetrating disease and prior CD resections. The guidance also emphasizes the importance of addressing disease modifiers including NSAID use, cigarette smoking, diet, and management of stress, depression, and anxiety.
CNN
35 minutes ago
- CNN
RSV can cause severe disease for babies, this drug could prevent it
RSV is the most common cause of hospitalization in babies, but Sanofi is one of a few companies producing a shot that can help prevent this potentially severe illness. CNN's Meg Tirrell tours one of their facilities.
